The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

NEW YORK, Dec. 12 (UPI ... However, those who take prescription weight-loss drugs lose, on average, up to 15% of excess body weight, Garvey said, which lowers their risk for related health ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Next up, the prescription weight loss drug lorcaserin (Belviq ... in the late 1990s the FDA recommended that new medications to treat obesity undergo yearlong clinical trials before approval.

GLP-1 drugs like Ozempic have swept the world as effective therapies for far more than their original target of diabetes.

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...